Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orlistat effects on gut microbiota and metabolic parameters in Japanese obese men
jRCTs071190050Completed
- Sponsor
- Taisho Pharmaceutical
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of orlistat in obesity, sponsored by Taisho Pharmaceutical. Started Jun 2020; status: completed.
02
Drugs
orlistat
03
Conditions
obesity
Beyond the preview
Go deeper on jRCTs071190050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071190050.